Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Oliff

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Breast Cancer Research and Treatment|January 1, 1996
Farnesyltransferase inhibitors and anti-Ras therapyJ B Gibbs, N E Kohl, K S Koblan, et al.
Biofactors (Oxford, England)|January 1, 1997
Farnesyl: proteintransferase inhibitors as agents to inhibit tumor growthC A Omer, N J Anthony, C A Buser-Doepner, et al.
Nature Medicine|November 4, 2000
A peptide-doxorubicin 'prodrug' activated by prostate-specific antigen selectively kills prostate tumor cells positive for prostate-specific antigen in vivoD DeFeo-Jones, V M Garsky, B K Wong, et al.
Molecular and Cellular Biology|January 7, 1998
A farnesyltransferase inhibitor induces tumor regression in transgenic mice harboring multiple oncogenic mutations by mediating alterations in both cell cycle control and apoptosisR E Barrington, M A Subler, E Rands, et al.
The Lancet. Respiratory Medicine|September 12, 2024
Plinabulin plus docetaxel versus docetaxel in patients with non-small-cell lung cancer after disease progression on platinum-based regimen (DUBLIN-3): a phase 3, international, multicentre, single-blind, parallel group, randomised controlled trialBaohui Han, Trevor Feinstein, Yuankai Shi, et al.
Cancer Research|May 29, 2000
Mouse mammary tumor virus-Ki-rasB transgenic mice develop mammary carcinomas that can be growth-inhibited by a farnesyl:protein transferase inhibitorC A Omer, Z Chen, R E Diehl, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Breast Cancer Research and Treatment|January 1, 1996
Farnesyltransferase inhibitors and anti-Ras therapyJ B Gibbs, N E Kohl, K S Koblan, et al.
Biofactors (Oxford, England)|January 1, 1997
Farnesyl: proteintransferase inhibitors as agents to inhibit tumor growthC A Omer, N J Anthony, C A Buser-Doepner, et al.
Nature Medicine|November 4, 2000
A peptide-doxorubicin 'prodrug' activated by prostate-specific antigen selectively kills prostate tumor cells positive for prostate-specific antigen in vivoD DeFeo-Jones, V M Garsky, B K Wong, et al.
Molecular and Cellular Biology|January 7, 1998
A farnesyltransferase inhibitor induces tumor regression in transgenic mice harboring multiple oncogenic mutations by mediating alterations in both cell cycle control and apoptosisR E Barrington, M A Subler, E Rands, et al.
The Lancet. Respiratory Medicine|September 12, 2024
Plinabulin plus docetaxel versus docetaxel in patients with non-small-cell lung cancer after disease progression on platinum-based regimen (DUBLIN-3): a phase 3, international, multicentre, single-blind, parallel group, randomised controlled trialBaohui Han, Trevor Feinstein, Yuankai Shi, et al.
Cancer Research|May 29, 2000
Mouse mammary tumor virus-Ki-rasB transgenic mice develop mammary carcinomas that can be growth-inhibited by a farnesyl:protein transferase inhibitorC A Omer, Z Chen, R E Diehl, et al.
Pageof 9